CD8A and melanoma: First, in immunocompetent mice bearing ovalbumin (OVA)-expressing melanomas, we identified endogenous OVA-specific CD8 tumor-infiltrating lymphocytes (TILs) showing reduced viability compared to non-specific T cells (Figure S1A), in agreement with AICD by intense antigen stimulation.